EV/EBITDA:
-19.27-0.19(-1.00%)Summary
- As of today (July 1, 2025), AXSM EV/EBITDA is -19.27, with a fall of -0.19 (-1.00%) during the most recent trading session on June 30, 2025.
- Over the past year, AXSM EV/EBITDA has dropped by -6.79 (-54.41%).
- AXSM EV/EBITDA is now -1382.31% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.0% | +1.0% | +1.0% |
| 1 m1 month | +0.8% | -0.8% | -0.7% |
| 3 m3 months | +7.1% | -10.7% | -11.9% |
| 6 m6 months | -44.5% | +26.8% | +23.1% |
| ytdytd | - | - | +23.4% |
| 1 y1 year | -54.4% | +35.6% | +29.7% |
| 5 y5 years | +37.8% | +74.4% | +26.9% |
AXSM EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.58 | -3.7% | -20.69 | +6.9% |
| 3 m | 3-month | -17.63 | -9.3% | -21.57 | +10.7% |
| 6 m | 6-month | -13.34 | -44.5% | -24.36 | +20.9% |
| 1 y | 1-year | -12.23 | -57.6% | -24.36 | +20.9% |
| 3 y | 3-year | -10.41 | -85.1% | -27.29 | +29.4% |
| 5 y | 5-year | -6.06 | -218.0% | -32.40 | +40.5% |
| alltime | all time | -1.30 | -1382.3% | -74.77 | +74.2% |
AXSM EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -19.27(+21.3%) |
| 2023 | -15.88(-14.3%) |
| 2022 | -18.52(+64.3%) |
| 2021 | -11.27(-61.2%) |
| 2020 | -29.04(-46.2%) |
| Date | Value |
|---|---|
| 2019 | -53.94(+1966.7%) |
| 2018 | -2.61(-39.4%) |
| 2017 | -4.31(+13.7%) |
| 2016 | -3.79(-66.2%) |
| 2015 | -11.21 |
FAQ
- What is Axsome Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Axsome Therapeutics?
- What is Axsome Therapeutics EV/EBITDA year-on-year change?
What is Axsome Therapeutics EV/EBITDA?
The current EV/EBITDA of AXSM is -19.27
What is the all time high EV/EBITDA for Axsome Therapeutics?
Axsome Therapeutics all-time high EV/EBITDA is -1.30
What is Axsome Therapeutics EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by -6.79 (-54.41%)